Common gastrointestinal side effects include nausea, diarrhoea, constipation, and abdominal pain, typically emerging during treatment initiation or dose escalation
According to the MHRA/EMC Summary of Product Characteristics (SmPC), these include: Nausea and vomiting often most pronounced during dose escalation Diarrhoea or constipation affecting bowel regularity Abdominal pain and discomfort typically mild to moderate Reduced appetite a therapeutic effect that may feel uncomfortable initially Dyspepsia indigestion or heartburn These gastrointestinal effects usually diminish over time as the body adjusts to treatment
How Much Weight Do People Lose on Semaglutide
Its key to ask about costs upfront to avoid surprises before starting any treatment
Under these conditions, retatrutide still about doubled FOC (increase by 289% after 100 nM compared to force before retatrutide, or from 2.01 0.33 mN to 7.29 1.05 mN, n = 8)
Additionally, it serves as a recognition of the enduring challenges faced beyond just the physical symptoms